[HTML][HTML] Significance of levocarnitine treatment in dialysis patients
H Takashima, T Maruyama, M Abe - Nutrients, 2021 - mdpi.com
Carnitine is a naturally occurring amino acid derivative that is involved in the transport of
long-chain fatty acids to the mitochondrial matrix. There, these substrates undergo β …
long-chain fatty acids to the mitochondrial matrix. There, these substrates undergo β …
Levocarnitine and dialysis: a review
B Schreiber - Nutrition in clinical practice, 2005 - Wiley Online Library
Among the various metabolic abnormalities documented in dialysis patients are
abnormalities related to the metabolism of fatty acids. Aberrant fatty‐acid metabolism has …
abnormalities related to the metabolism of fatty acids. Aberrant fatty‐acid metabolism has …
Levocarnitine and muscle metabolism in patients with end-stage renal disease
S Goral - Journal of Renal Nutrition, 1998 - Elsevier
Levocarnitine is a molecule required in mammalian energy metabolism. It removes the
potentially toxic acyl groups from the cell helping to maintain normal metabolic functions. In …
potentially toxic acyl groups from the cell helping to maintain normal metabolic functions. In …
Debate forum: levocarnitine therapy is rational and justified in selected dialysis patients
BD Schreiber - Blood purification, 2005 - karger.com
Carnitine is a metabolic cofactor which is essential for normal fatty acid metabolism. Patients
with chronic kidney disease on dialysis have been shown both to suffer from disordered fatty …
with chronic kidney disease on dialysis have been shown both to suffer from disordered fatty …
L carnitine in hemodialysis patients
Abstract Carnitine, 3‐hydroxy‐4‐trimethylaminobutyrate, a small, water soluble molecule
that is essential for mitochondrial fatty acid oxidation, is significantly reduced in hemodialysis …
that is essential for mitochondrial fatty acid oxidation, is significantly reduced in hemodialysis …
Dialysis-related carnitine disorder and levocarnitine pharmacology
A Evans - American journal of kidney diseases, 2003 - Elsevier
Among the homeostatic processes controlling the endogenous l-carnitine pool in humans,
the kidney has a vital role through extensive and adaptive tubular reabsorption. Kidney …
the kidney has a vital role through extensive and adaptive tubular reabsorption. Kidney …
Carnitine and hemodialysis
G Bellinghieri, D Santoro, M Calvani… - American journal of …, 2003 - Elsevier
Carnitine, gamma-trimethyl-beta-hydroxybutyrobetaine, is a small molecule widely present
in all cells from prokaryotic to eukaryotic. It is an important element in the beta-oxidation of …
in all cells from prokaryotic to eukaryotic. It is an important element in the beta-oxidation of …
HEMATOLOGY: ISSUES IN THE DIALYSIS PATIENT: Dialysis‐Related Carnitine Disorder
SS Hedayati - Seminars in dialysis, 2006 - Wiley Online Library
ABSTRACT L‐carnitine plays an essential role in the β‐oxidation of fatty acids by catalyzing
their transport into the mitochondrial matrix. The kidney maintains plasma free L‐carnitine …
their transport into the mitochondrial matrix. The kidney maintains plasma free L‐carnitine …
L‐carnitine in dialysis patients
S Ahmad - Seminars in dialysis, 2001 - Wiley Online Library
Hemodialysis (HD) patients often have low serum concentrations of free L‐carnitine and
decreased skeletal muscle stores. As L‐carnitine is an essential cofactor in fatty acid and …
decreased skeletal muscle stores. As L‐carnitine is an essential cofactor in fatty acid and …
Effects of levocarnitine on cardiac function and renal anemia in hemodialysis patients
T Higuchi - Recent Advances in Dialysis Therapy in Japan, 2018 - karger.com
Background: Carnitine deficiency is a common condition in hemodialysis patients. There
have been numerous reports on the efficacy of levocarnitine therapy in hemodialysis …
have been numerous reports on the efficacy of levocarnitine therapy in hemodialysis …